Biofrontera's Corporate Minority Round

Biofrontera raised a round of funding on April 26, 2012. Investors include Carsten Maschmeyer.

Biofrontera is an international biopharmaceutical company specializing in the development and commercialization of a platform of pharmaceutical products for the treatment of dermatological conditions …

Articles about Biofrontera's Corporate Minority Round: